Go to Page # Page of 48

Developing Breakthrough Therapies in Nash & Mucopolysaccharidosis

 Frédéric Cren, Pierre Broqua PhD, Jean Volatier, Marie-Paule Richard MD
Description: Inventiva investment highlights for clinical stage biotech with a focus on oral small molecules for high unmet need in fibrosis, lysosomal storage disorders and oncology.
Views: 1199
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: Inventiva
 ‐ More of their Presentations
Developing breakthrough therapies in
NASH and mucopolysaccharidosis
Corporate Presentation
April 2019

This document has been prepared by Inventiva (the "Company") solely for the purpose of this presentation. This presentation includes only summary information and does not purport to be
comprehensive. Any information in this presentation, whether from internal or from external sources, ... See more

Recent Presentations

19 September, 2019
18 September, 2019
17 September, 2019